Research - January 2016 Archives

DEAR MAYO CLINIC: Do I need to be in a clinical trial to get access to an investigational drug? If so, how do I find ...

Rochester, MINN. — Mayo Clinic Cancer Center has joined 68 other top cancer centers that have issued a statement urging for increased HPV vaccination ...

ROCHESTER, Minn.  — Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated ...

ROCHESTER, Minn. – A Mayo Clinic study of people who received anesthesia for surgery after age 40 found no association between the anesthesia and ...

  According to the first-ever Mayo Clinic National Health Check-Up, most Americans experience barriers to staying healthy, with their work schedule as the leading barrier ...

ROCHESTER, Minn. — Mayo Clinic has added robots in its fight against Clostridium difficile (C-diff) bacteria. In the U.S., C-diff is one of the most ...

Robert Diasio, M.D., director of the Mayo Clinic Cancer Center (center) joined leaders from the Masonic Cancer Center at the University of Minnesota and the ...

ROCHESTER, Minn. – Alzheimer’s disease relentlessly targets large-scale brain networks that support the formation of new memories. However, it remains a mystery as to ...

A type of heartburn medication called proton pump inhibitors (PPIs) may be linked to long-term kidney damage, according to a new study published in ...

ROCHESTER, Minn. — Radiation therapy was associated with a lower risk of cancer recurrence in pancreatic cancer surgery patients, making it, like chemotherapy, an important addition to treatment, Mayo Clinic research found. Whether radiotherapy helps patients after pancreatic cancer surgery has been a long-standing question, and the findings suggest that it does, says senior author Christopher Hallemeier, M.D., a radiation oncologist at the Mayo Clinic Cancer Center. The study is published in the American Society for Radiation Oncology’s  International Journal of Radiation Oncology, Biology, Physics. The researchers studied 458 patients who had pancreatic cancer surgery at Mayo Clinic between March 1987 and January 2011. Of those patients, 378 received chemotherapy and radiation therapy after surgery, and 80 had only chemotherapy after their operations. Eighty percent of those who received chemotherapy and radiation after surgery had no recurrence of cancer within the area targeted by the radiation, the tumor bed and lymph nodes, within five years after diagnosis. That compared with 68 percent of those who had chemotherapy only following their operations. Additionally, patients who received radiotherapy had longer survival times. Over the past five years or so, the trend has been toward providing chemotherapy and radiation before surgery in an increasing number of patients with operable pancreatic cancer, Dr. Hallemeier says. He and his colleagues plan research to study the benefit of that, but first wanted to address the longtime question of whether radiation helps after surgery. “The role of radiation therapy in operable pancreatic cancer has been somewhat controversial. There have been some studies that have shown a benefit and some studies that have not shown a benefit,” Dr. Hallemeier says. Media contact: Sharon Theimer in Mayo Clinic Public Affairs, 507-284-5005 or newsbureau@mayo.edu

ROCHESTER, Minn. — Mayo Clinic researchers have taken what they hope will be the first step toward preventing and reversing age-related stem cell dysfunction and ...

On this special New Year's edition of Mayo Clinic Radio, we look back at some of the leading-edge research featured on the program in 2015. Dr. Robert ...